Option Care Health (NASDAQ:OPCH) Upgraded by UBS Group to Buy Rating

Option Care Health (NASDAQ:OPCH - Get Free Report) was upgraded by UBS Group from a "neutral" rating to a "buy" rating in a research report issued to clients and investors on Wednesday, MarketBeat reports. The firm currently has a $40.00 price objective on the stock, up from their previous price objective of $38.00. UBS Group's price target would suggest a potential upside of 22.72% from the company's previous close.

Several other equities analysts have also recently issued reports on OPCH. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and boosted their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research note on Monday, April 21st. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Option Care Health presently has a consensus rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Stock Down 1.1 %

Shares of OPCH traded down $0.36 during mid-day trading on Wednesday, hitting $32.60. 759,445 shares of the company's stock were exchanged, compared to its average volume of 1,822,888. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market cap of $5.34 billion, a price-to-earnings ratio of 27.40, a P/E/G ratio of 2.30 and a beta of 0.76. The stock's 50-day moving average is $33.35 and its 200-day moving average is $28.82. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same quarter last year, the company earned $0.26 EPS. Option Care Health's revenue for the quarter was up 16.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds have recently added to or reduced their stakes in OPCH. Vanguard Group Inc. raised its stake in Option Care Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock valued at $448,118,000 after acquiring an additional 75,313 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Option Care Health by 84.6% in the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after purchasing an additional 8,400,208 shares during the period. Dimensional Fund Advisors LP grew its position in Option Care Health by 17.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after buying an additional 591,042 shares in the last quarter. Northern Trust Corp increased its stake in Option Care Health by 11.8% during the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock valued at $60,934,000 after buying an additional 278,158 shares during the period. Finally, Norges Bank bought a new stake in shares of Option Care Health during the 4th quarter worth about $60,219,000. 98.05% of the stock is currently owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.